| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/12/2007 | CA2624170A1 Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal |
| 04/12/2007 | CA2624141A1 Quinazoline derivative and pharmaceutical |
| 04/12/2007 | CA2624122A1 Oral composition containing a salivation inducing agent |
| 04/12/2007 | CA2624111A1 Photostable pharmaceutical composition containing brivudine for the treatment of herpetic keratitis |
| 04/12/2007 | CA2624105A1 Phenyl-[1,2,4]-oxadiazol-5-one derivatives with phenyl group, processes for their preparation and their use as pharmaceuticals |
| 04/12/2007 | CA2624102A1 Phenyl- and pyridinyl- 1, 2 , 4 - oxadiazolone derivatives, processes for their preparation and their use as pharmaceuticals |
| 04/12/2007 | CA2624100A1 Derivatives of 2 -aminthiazoles and 2-aminooxazoles, processes for their preparation and their use as pharmaceuticals |
| 04/12/2007 | CA2624096A1 Benzothiadiazolyphenylalkylamine derivatives for use in the treatment of conditions ameliorated by monoamine reuptake |
| 04/12/2007 | CA2624093A1 Phenyl- and pyridyl-i,2,4 -oxadiazolone derivatives with phenyl group, processes for their preparation and their use as pharmaceuticals |
| 04/12/2007 | CA2624088A1 Sustained release small molecule drug formulation |
| 04/12/2007 | CA2624032A1 Cholesteryl ester transfer protein inhibitors |
| 04/12/2007 | CA2624031A1 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 04/12/2007 | CA2624030A1 Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators |
| 04/12/2007 | CA2624015A1 Novel c18 modified retrosteroids as progesterone receptor modulator compounds |
| 04/12/2007 | CA2624011A1 Normalization or remission of microalbuminuria |
| 04/12/2007 | CA2623848A1 Topical anesthetic for dental procedures |
| 04/12/2007 | CA2623826A1 Dpp iv inhibitor for use in the treatment of autoimmune diseases and graft rejection |
| 04/12/2007 | CA2623822A1 1h-benzimidazole-4-carboxamides substituted with phenyl at the 2-position are potent parp inhibitors |
| 04/12/2007 | CA2623818A1 Aptamers comprising arabinose modified nucleotides |
| 04/12/2007 | CA2623813A1 Nitrogen-containing heterocyclic compound and pharmaceutical application thereof |
| 04/12/2007 | CA2623731A1 Vitamin d derivatives active on the vitamin d nuclear receptor, preparation and uses thereof |
| 04/12/2007 | CA2623728A1 Nnrt inhibitors |
| 04/12/2007 | CA2623722A1 Indane derivatives as mch receptor antagonists |
| 04/12/2007 | CA2623721A1 Oxadiazolyl pyrazolo-pyrimidines as mglur2 antagonists |
| 04/12/2007 | CA2623715A1 Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists |
| 04/12/2007 | CA2623657A1 Pde inhibitors and combinations thereof for the treatment of urological disorders |
| 04/12/2007 | CA2623638A1 Treatment of cancer with specific rxr agonists |
| 04/12/2007 | CA2623534A1 Inhibitors of the hiv integrase enzyme |
| 04/12/2007 | CA2623359A1 9-azabicyclo [3.3.1] nonane derivatives as monoamine reuptake inhibitors |
| 04/12/2007 | CA2623348A1 Biaryl substituted heterocycle inhibitors of lta4h for treating inflammation |
| 04/12/2007 | CA2623237A1 Novel dosage formulation |
| 04/12/2007 | CA2623201A1 Pharmaceutical preparation containing meloxicam |
| 04/12/2007 | CA2623154A1 Novel fused pyrrole derivative |
| 04/12/2007 | CA2623114A1 Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment |
| 04/12/2007 | CA2623058A1 Pyrimidine compounds for the treatment of inflammatory disorders |
| 04/12/2007 | CA2623045A1 Sulfonamide derivatives as glycokinase activators useful in the treatment of type 2 diabetes |
| 04/12/2007 | CA2623043A1 Isoxazolo derivatives as gaba a alpha5 inverse agonists |
| 04/12/2007 | CA2623032A1 Deazapurines useful as inhibitors of janus kinases |
| 04/12/2007 | CA2623031A1 Antifungal composition |
| 04/12/2007 | CA2623011A1 New formulation |
| 04/12/2007 | CA2623009A1 5- (phenylisoxazolylethoxy) -triazol- 3 -yl substituted pyridine compounds for the treatment of neurological, psychiatric or pain disorders |
| 04/12/2007 | CA2622944A1 Diazine azole derivatives, their manufacture and use as pharmaceutical agents |
| 04/12/2007 | CA2622935A1 Novel nitrocatechol derivatives having selectin ligand activity |
| 04/12/2007 | CA2622822A1 Controlled release pharmaceutical composition of venlafaxine hydrochloride, and process for preparation thereof |
| 04/12/2007 | CA2622673A1 Sulphonylpyrroles and use thereof as inhibitors of hdac s |
| 04/12/2007 | CA2622670A1 Sulphonylpyrrole hydrochloride salts as histone deacetylases inhibitors |
| 04/12/2007 | CA2622467A1 Novel phloroglucinol derivatives having selectin ligand activity |
| 04/12/2007 | CA2622352A1 Substituted pyrazole compounds |
| 04/12/2007 | CA2622267A1 Novel multi-cyclic compounds and their use |
| 04/12/2007 | CA2622193A1 Antibiotic formulations, unit doses, kits, and methods |
| 04/12/2007 | CA2621152A1 Pharmaceutical compositions of a 5-ht2a serotonin receptor modulator useful for the treatment of disorders related thereto |
| 04/12/2007 | CA2621040A1 4-phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives |
| 04/12/2007 | CA2620018A1 Stable combinations of amlodipine besylate and benazepril hydrochloride |
| 04/12/2007 | CA2619457A1 Method of drug design |
| 04/12/2007 | CA2609953A1 Saccharide foamable compositions |
| 04/12/2007 | CA2586420A1 Enhancing treatment of cancer and hif-1 mediated disoders with adenosine a3 receptor antagonists |
| 04/12/2007 | CA2575827A1 Antiepileptogenic complex of albumin with docosahexaenoate |
| 04/11/2007 | EP1772514A2 Manipulation of tissue or organ type using the notch pathway |
| 04/11/2007 | EP1772462A2 Steroid sulfamates, method for the production and use thereof |
| 04/11/2007 | EP1772457A2 Preparation of levofloxacin and forms thereof |
| 04/11/2007 | EP1772456A1 Novel crystalline polymorphs of clopidogrel |
| 04/11/2007 | EP1772454A1 Nitrogenous fused bicyclic compound |
| 04/11/2007 | EP1772452A2 Matrix metalloproteinase inhibitors and uses thereof |
| 04/11/2007 | EP1772155A1 Medicament for treating avian influenza |
| 04/11/2007 | EP1772153A2 Method for the prevention of tissue elastic fiber injury |
| 04/11/2007 | EP1772152A2 Composition for inducing immunotolerance |
| 04/11/2007 | EP1772151A2 Method and compositions for the synthesis of bch-189 and related compounds |
| 04/11/2007 | EP1772150A1 Benzothiophene formulations of a specific dosage |
| 04/11/2007 | EP1772149A1 Drug for prevention or treatment of diabetes |
| 04/11/2007 | EP1772148A1 Lipase inhibitors |
| 04/11/2007 | EP1772147A2 Method for increasing the oral bioavailability of S-[2-([[1-(2-ethylbutyl)cyclohexyl]carbonyl]amino)phenyl]-2-methylpropanethioate |
| 04/11/2007 | EP1772146A1 Polyunsaturated fatty acids as bace inhibitors |
| 04/11/2007 | EP1772145A1 Method of effectively using medicine and method concerning prevention of side effect |
| 04/11/2007 | EP1772144A2 Novel sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using them |
| 04/11/2007 | EP1772143A1 Peroxisome proliferator-activated receptor (ppar) activator and drugs, supplements, functional foods and food additives using the same |
| 04/11/2007 | EP1772142A2 Organic compounds |
| 04/11/2007 | EP1772141A1 Method for effecting solid state crystallization |
| 04/11/2007 | EP1772066A1 Health food, process for producing the same and dried matter or extract |
| 04/11/2007 | EP1771733A2 Arrays with cleavable linkers |
| 04/11/2007 | EP1771732A2 Taxol immunoassay |
| 04/11/2007 | EP1771558A2 Inhibition of biofilm formation |
| 04/11/2007 | EP1771548A1 Use of dendrimers to stimulate cell growth |
| 04/11/2007 | EP1771461A2 Novel 2-substituted estra-1,3,5(10)-trien-17-ones used in the form of inhibitors of 17beta-hydroxysteroiddehydrogenase of type 1 |
| 04/11/2007 | EP1771460A1 Methylidene-d-xylopyranosyl-substituted and oxo-d-xylopyranosyl-substituted phenyls, medicaments containing these compounds, their use and method for the production thereof |
| 04/11/2007 | EP1771458A1 N-phenylphosphoric acid triamides, method for the production thereof and their use as agents for regulating or inhibiting enzymatic urea hydrolysis |
| 04/11/2007 | EP1771456A2 Hybrid qa molecules wherein q is an aminoquinoline and a is an antibiotic residue, their synthesis and their uses as antibacterial agent |
| 04/11/2007 | EP1771455A2 Oxidative degradation products of atorvastatin calcium |
| 04/11/2007 | EP1771454A1 Hepatitis c inhibitor peptide analogs |
| 04/11/2007 | EP1771453A1 Hepatitis c inhibitor dipeptide analogs |
| 04/11/2007 | EP1771452A2 Inhibitors of 5'-methylthioadenosine phosphorylase and 5'methylthioadenosine/s-adenosylhomocysteine nucleosidase |
| 04/11/2007 | EP1771450A2 Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase |
| 04/11/2007 | EP1771449A1 Histamine-3 receptor antagonists |
| 04/11/2007 | EP1771448A1 Azaindole carboxamides |
| 04/11/2007 | EP1771447A1 Fused pyrimidine derivatives and compositions thereof as cxcr3 receptor modulators, useful in prevention and treatment of inflammatory and immunoregulatory disorders and diseases |
| 04/11/2007 | EP1771446A2 Azaindole inhibitors of mtp and apob |
| 04/11/2007 | EP1771445A1 Dimeric compounds of piperidine, piperazine or morpholine or their 7-membered analogs suitabale for the treatment of neurodegenerative disorders |
| 04/11/2007 | EP1771444A1 Salt of oxalic acid with 5-[4-[2-(n-methyl-n-(2-pyridyl)-amino)ethoxy]benzyl]thiazolidin-2,4-dione and a method of its preparation and its use |
| 04/11/2007 | EP1771443A1 Quinoline thiazolinones with cdk1 antiproliferative activity |
| 04/11/2007 | EP1771442A1 Viral polymerase inhibitors |
| 04/11/2007 | EP1771441A1 Novel carboxamides for use as xa inhibitors |